Consolidated Research: 2018 Summary Expectations for Kimball Electronics, Madrigal Pharmaceuticals, American Railcar Industries, H&R Block, Biogen, and Equinix — Fundamental Analysis, Key Performance Indications

2/5/2018, 1:35 PM (Source: GlobeNewswire)

NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kimball Electronics, Inc. (NASDAQ:KE), Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), American Railcar Industries, Inc. (NASDAQ:ARII), H&R Block, Inc. (NYSE:HRB), Biogen Inc. (NASDAQ:BIIB), and Equinix, Inc. (NASDAQ:EQIX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

KE DOWNLOAD: http://Fundamental-Markets.com/register/?so=KE
MDGL DOWNLOAD:
http://Fundamental-Markets.com/register/?so=MDGL
ARII DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ARII
HRB DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HRB
BIIB DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BIIB
EQIX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=EQIX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Kimball Electronics, Inc. (NASDAQ:KE), Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), American Railcar Industries, Inc. (NASDAQ:ARII), H&R Block, Inc. (NYSE:HRB), Biogen Inc. (NASDAQ:BIIB), and Equinix, Inc. (NASDAQ:EQIX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 2nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Kimball Electronics, Inc. (KE) REPORT OVERVIEW

Kimball Electronics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Kimball Electronics reported revenue of $253.20MM vs $226.45MM (up 11.81%) and basic earnings per share $0.32 vs $0.36 (down 11.11%). For the twelve months ended June 30th, 2017 vs June 30th, 2016, Kimball Electronics reported revenue of $930.91MM vs $842.06MM (up 10.55%) and basic earnings per share $1.25 vs $0.77 (up 62.34%). Kimball Electronics is expected to report earnings on February 7th, 2018. The report will be for the fiscal period ending December 31st, 2017.

To read the full Kimball Electronics, Inc. (KE) report, download it here: http://Fundamental-Markets.com/register/?so=KE

-----------------------------------------

Madrigal Pharmaceuticals, Inc. (MDGL) REPORT OVERVIEW

Madrigal Pharmaceuticals' Recent Financial Performance

Madrigal Pharmaceuticals is expected to report earnings on April 2nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.67. The estimated EPS forecast for the next fiscal year is -$3.24 and is expected to report on April 2nd, 2018.

To read the full Madrigal Pharmaceuticals, Inc. (MDGL) report, download it here: http://Fundamental-Markets.com/register/?so=MDGL

-----------------------------------------

American Railcar Industries, Inc. (ARII) REPORT OVERVIEW

American Railcar Industries' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, American Railcar Industries reported revenue of $120.75MM vs $144.96MM (down 16.71%) and basic earnings per share $0.46 vs $0.40 (up 15.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, American Railcar Industries reported revenue of $639.13MM vs $889.34MM (down 28.13%) and basic earnings per share $3.74 vs $6.39 (down 41.47%). American Railcar Industries is expected to report earnings on February 23rd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.16. The estimated EPS forecast for the next fiscal year is $2.43 and is expected to report on February 23rd, 2018.

To read the full American Railcar Industries, Inc. (ARII) report, download it here: http://Fundamental-Markets.com/register/?so=ARII

-----------------------------------------

H&R Block, Inc. (HRB) REPORT OVERVIEW

H&R Block's Recent Financial Performance

For the three months ended October 31st, 2017 vs October 31st, 2016, H&R Block reported revenue of $140.85MM vs $131.33MM (up 7.25%) and basic earnings per share -$0.74 vs -$0.68. For the twelve months ended April 30th, 2017 vs April 30th, 2016, H&R Block reported revenue of $3,036.31MM vs $3,038.15MM (down 0.06%) and basic earnings per share $1.92 vs $1.50 (up 28.00%). H&R Block is expected to report earnings on March 6th, 2018. The report will be for the fiscal period ending January 31st, 2018. The reported EPS for the same quarter last year was -$0.49. The estimated EPS forecast for the next fiscal year is $2.24 and is expected to report on June 12th, 2018.

To read the full H&R Block, Inc. (HRB) report, download it here: http://Fundamental-Markets.com/register/?so=HRB

-----------------------------------------

Biogen Inc. (BIIB) REPORT OVERVIEW

Biogen's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Biogen reported revenue of $3,307.00MM vs $2,872.00MM (up 15.15%) and basic earnings per share -$1.40 vs $3.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Biogen reported revenue of $12,273.90MM vs $11,448.80MM (up 7.21%) and basic earnings per share $11.94 vs $16.96 (down 29.60%). Biogen is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $5.20. The estimated EPS forecast for the next fiscal year is $25.64 and is expected to report on January 24th, 2019.

To read the full Biogen Inc. (BIIB) report, download it here: http://Fundamental-Markets.com/register/?so=BIIB

-----------------------------------------

Equinix, Inc. (EQIX) REPORT OVERVIEW

Equinix's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Equinix reported revenue of $1,152.26MM vs $924.68MM (up 24.61%) and basic earnings per share $1.02 vs $0.73 (up 39.73%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Equinix reported revenue of $3,611.99MM vs $2,725.87MM (up 32.51%) and basic earnings per share $1.81 vs $3.25 (down 44.31%). Equinix is expected to report earnings on February 14th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $4.08. The estimated EPS forecast for the next fiscal year is $18.64 and is expected to report on February 14th, 2018.

To read the full Equinix, Inc. (EQIX) report, download it here: http://Fundamental-Markets.com/register/?so=EQIX

-----------------------------------------

ABOUT Fundamental Markets

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.